Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hubschwerlen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Solid- and solution-phase synthesis of highly-substituted-pyrrolidine librariesM Steger, C Hubschwerlen, G Schmid
Antimicrobial Agents and Chemotherapy|December 1, 1992
Antibacterial properties of Ro 40-6890, a broad-spectrum cephalosporin, and its novel orally absorbable ester, Ro 41-3399P Angehrn, P Hohl, C Hubschwerlen, et al.
The Journal of Biological Chemistry|October 16, 1999
Methanopyrus kandleri glutamyl-tRNA reductaseJ Moser, S Lorenz, C Hubschwerlen, et al.
Journal of Medicinal Chemistry|October 10, 1998
Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazinsC Hubschwerlen, P Angehrn, K Gubernator, et al.
The Journal of Antibiotics|August 1, 1992
Orally active 2-(alkyloxycarbonyl)-2-alkylideneethyl esters of cephalosporinsC Hubschwerlen, R Charnas, P Angehrn, et al.
Journal of Medicinal Chemistry|February 26, 2000
Phenyl beta-methoxyacrylates: a new antimalarial pharmacophoreJ Alzeer, J Chollet, I Heinze-Krauss, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cellsC M Apfel, S Evers, C Hubschwerlen, et al.
Journal of Medicinal Chemistry|April 17, 1992
Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitorsC Hubschwerlen, P Pflieger, J L Specklin, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Peptide deformylase as an antibacterial drug target: target validation and resistance developmentC M Apfel, H Locher, S Evers, et al.
Journal of Medicinal Chemistry|September 13, 1996
Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamasesH G Richter, P Angehrn, C Hubschwerlen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Solid- and solution-phase synthesis of highly-substituted-pyrrolidine librariesM Steger, C Hubschwerlen, G Schmid
Antimicrobial Agents and Chemotherapy|December 1, 1992
Antibacterial properties of Ro 40-6890, a broad-spectrum cephalosporin, and its novel orally absorbable ester, Ro 41-3399P Angehrn, P Hohl, C Hubschwerlen, et al.
The Journal of Biological Chemistry|October 16, 1999
Methanopyrus kandleri glutamyl-tRNA reductaseJ Moser, S Lorenz, C Hubschwerlen, et al.
Journal of Medicinal Chemistry|October 10, 1998
Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazinsC Hubschwerlen, P Angehrn, K Gubernator, et al.
The Journal of Antibiotics|August 1, 1992
Orally active 2-(alkyloxycarbonyl)-2-alkylideneethyl esters of cephalosporinsC Hubschwerlen, R Charnas, P Angehrn, et al.
Journal of Medicinal Chemistry|February 26, 2000
Phenyl beta-methoxyacrylates: a new antimalarial pharmacophoreJ Alzeer, J Chollet, I Heinze-Krauss, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cellsC M Apfel, S Evers, C Hubschwerlen, et al.
Journal of Medicinal Chemistry|April 17, 1992
Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitorsC Hubschwerlen, P Pflieger, J L Specklin, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Peptide deformylase as an antibacterial drug target: target validation and resistance developmentC M Apfel, H Locher, S Evers, et al.
Journal of Medicinal Chemistry|September 13, 1996
Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamasesH G Richter, P Angehrn, C Hubschwerlen, et al.
Pageof 2